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A major challenge of the post-genomics era is to
define the connectivity of protein phosphorylation
networks. Here, we quantitatively delineate the insu-
lin signaling network in adipocytes by high-resolution
mass spectrometry-based proteomics. These data
reveal the complexity of intracellular protein phos-
phorylation. We identified 37,248 phosphorylation
sites on 5,705 proteins in this single-cell type, with
approximately 15% responding to insulin. We inte-
grated these large-scale phosphoproteomics data
using a machine learning approach to predict physi-
ological substrates of several diverse insulin-
regulated kinases. This led to the identification of
an Akt substrate, SIN1, a core component of the
mTORC2 complex. The phosphorylation of SIN1 by
Akt was found to regulate mTORC2 activity in
response to growth factors, revealing topological
insights into the Akt/mTOR signaling network. The
dynamic phosphoproteome described here contains
numerous phosphorylation sites on proteins involved
in diverse molecular functions and should serve as a
useful functional resource for cell biologists.
INTRODUCTION
Insulin plays a major role in controlling metabolic homeostasis,
cellular growth, proliferation, and survival, and defects in
the mechanisms underlying these processes contribute to a
range of diseases including type 2 diabetes, cardiovascular
disease, and cancer. Protein phosphorylation plays a major
role in almost all insulin-regulated processes. As a member of
the receptor tyrosine kinase (RTK) family, the insulin receptor
engages the canonical phosphoinositide-3 kinase (PI3K)/
Akt (Manning and Cantley, 2007) and mammalian target of
rapamycin (mTOR) pathways (Zoncu et al., 2011), which
together coordinate many of insulin’s actions. These pathways
are a major convergence point for many RTKs, and hyperacti-
vation of the PI3K-Akt and mTOR pathways occur in many
human tumors (Laplante and Sabatini, 2012; Yuan and Cantley,
2008).Cell MThe mTOR-regulated phosphoproteome was recently investi-
gated using quantitative mass spectrometry (MS). By examining
the sensitivity to the mTOR inhibitors Torin1, rapamycin, and Ku-
0063794, the mTOR network in HEK293 cells and Tsc2/
mouse embryonic fibroblasts (MEFs) was assessed to a depth
of 4,251 and 7,255 phosphosites, respectively (Hsu et al.,
2011; Yu et al., 2011). Surprisingly, few studies have examined
the diversity of the Akt network on a global scale. It is reported
that Akt phosphorylates in excess of 100 substrates; however,
many of these sites were identified using targeted approaches.
Moreover, the extent to which hormones such as insulin rely
on signaling nodes other than the canonical PI3K/Akt pathway
for their physiologic functions remains uncertain. Therefore, to
obtain a more complete view of the PI3K/Akt network, it would
be desirable to take an unbiased approach using quantitative
MS. To delineate the complexity of the insulin signaling network,
we generated dynamic maps of the insulin-regulated phospho-
proteome in insulin-responsive 3T3-L1 adipocytes. To investi-
gate the role played by the key insulin-regulated kinases Akt
and PI3K, we combined these approaches with pharmacological
inhibitors targeting these signaling nodes. This revealed a com-
plex single-cell phosphorylation network comprising 37,248
phosphorylation sites on 5,705 proteins, 15% of which were in-
sulin regulated. There was considerable diversity in the temporal
pattern of phosphorylation among different insulin-responsive
targets. We demonstrate the utility of these large phosphopro-
teome data sets for the identification of insulin-regulated phos-
phorylation sites by developing and applying a general in silico
machine learning approach to systematically predict kinase-
substrate relationships. This strategy builds upon existing
methods based on identification of kinase consensus motifs
(Linding et al., 2008; Obata et al., 2000; Obenauer et al., 2003)
or chemical-genetic approaches (Blethrow et al., 2008; Chi
et al., 2008) while overcoming problems associated with con-
sensus motif redundancy and preserving the specificity and
context of the cellular environment.
RESULTS
Quantification of the Adipocyte Phosphoproteome
To characterize the insulin signaling network we applied two
distinct quantitative phosphoproteomics strategies using stable
isotope labeling with amino acids in cell culture (SILAC) (Ong and
Mann, 2006). In the first set of experiments, we quantified theetabolism 17, 1009–1020, June 4, 2013 ª2013 The Authors 1009
Figure 1. Quantification of the Insulin-Regulated Phosphoproteome using Tandem Mass Spectrometry
(A) Experimental design of inhibitor screens.
(B) Experimental design of temporal phosphoproteome screen.
(C) Workflow for the proteome and phosphoproteome analysis.
(D) Summary of the quantified phosphoproteome and proteome.
(E) Efficiency of phosphopeptide enrichment for a representative experiment. Above each bar is the percent of the total identified peptides in each fraction that
were phosphorylated.
(F) Quantitative reproducibility for a representative experiment of one of the large-scale MS studies. See also Figures S1 and S2 and Tables S1, S2, and S3.
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Dynamic Adipocyte Phosphoproteomeinsulin-regulated phosphoproteome using two potent and selec-
tive kinase inhibitors targeting Akt (MK2206) and PI3K/mTOR
(LY294002) (Figure 1A). In the second series of experiments we
employed a multiplexed SILAC approach to interrogate the tem-
poral profile of insulin signaling over a wide temporal dynamic
range spanning 15 s to 60 min (Figure 1B). All MS experiments
were performed in triplicate. We achieved high confidence and
deep coverage of the phosphoproteome by analyzing a large
number of phosphopeptide-enriched fractions and by taking
advantage of recent developments in MS hardware (Michalski
et al., 2011) and software (Cox and Mann, 2008; Cox et al.,
2011) (Figure 1C). In total, 7,441,138 high-resolution (Orbitrap
higher-energy collision dissociation [HCD]) spectra were
acquired, resulting in the identification of 38,901 unique phos-1010 Cell Metabolism 17, 1009–1020, June 4, 2013 ª2013 The Authophopeptides corresponding to 37,248 phosphorylation sites on
5,705 proteins (Figure 1D and Tables S1 and S2), placing this
among the largest phosphoproteomes reported. Phosphopep-
tide identification confidence was high, with 95% of all peptides
identified having an absolute mass deviation less than 2 ppm
(Figures S1A and S1B).
Our phosphopeptide enrichment was highly efficient and
selective, since phosphopeptides consisted of an average of
83% of the total peptides identified from the phosphopeptide-
enriched samples (Figure 1E) and reproducibility of phospho-
peptide quantitation between biological replicates was good
(Figure 1F). Single-, double-, triple-, and higher-phosphorylated
peptides represented 72%, 23%, 4% and <1% of the total
phosphopeptides, respectively (Figure S1C). Based on thers
Figure 2. Dynamic Range and Enrichment of GO Terms in Adipocyte Proteome and Phosphoproteome
(A) Abundance of detected proteome was estimated using the summed peptide intensities of each protein, and proteins were ranked by abundance and divided
into four quartiles. Enrichment of protein GO terms (biological process and cellular component) in each protein abundance quartile was assessed by Fisher’s
exact test (FDR < 0.01 following Benjamini-Hochberg correction). The position of GO terms along the horizontal axis represents enrichment of these terms within
the respective protein abundance quartile.
(B) Frequency and significance of enrichment or de-enrichment of GOCC terms in the proteome and phosphoproteome (Fisher’s exact test, FDR < 0.01 after
Benjamini-Hochberg correction). See also Table S4.
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phorylation sites in each peptide, MaxQuant derived a phos-
phorylation site localization probability score (Olsen et al.,
2006). We divided the phosphoproteome into four categories
based on this probability score: class I (>0.75), class II
(0.75–0.5), class III (0.5–0.25), and class IV (<0.25). Importantly,
due to the 1% false discovery rate (FDR) applied at the peptide
(peptide-spectral matching), protein (protein group assembly),
and site (posttranslational modification [PTM] assignment) levels
(Cox and Mann, 2008), the probability that all peptides are phos-
phorylated is greater than 99%. Using this classification, 63% of
the sites in our phosphoproteome were accurately localized
(class I, Figure S1D) (median localization probability for all sites
was 0.96). Assessment of class I phosphopeptides revealed a
distribution of 87.8% phosphoserine, 11.4% phosphothreonine,
and 0.8% phosphotyrosine (Figure S1D) residues, which is
similar to previously reported phosphorylated amino acid distri-
butions (Olsen et al., 2006).
A Ranked Abundance Atlas of Adipocyte Protein
Expression
In parallel with the phosphoproteome studies, we retained a frac-
tion of the peptides for total proteome analysis by MS following
strong anion exchange chromatography (Figure 1C) (Wisniewski
et al., 2009), allowing us to place identified phosphoproteins in
the context of the adipocyte proteome. Combinedwith the phos-
phoproteome data, we identified a total of 8,676 proteins in 3T3-
L1 adipocytes with amedian peptide sequence coverage of 23%
(Figure 1D). Utilizing the normalized peptide intensities derived
from summation of measured peptide-extracted ion chromato-
grams (intensity-based absolute quantification [iBAQ]) (Schwan-
ha¨usser et al., 2011), we quantified and ranked the abundance ofCell Mthe 3T3-L1 adipocyte proteome (Table S4 and Figure 2A). These
data revealed that this cell line is highly specialized in metabolic
processes andmay have preservedmanymetabolic functions of
the tissue of origin. In addition to metabolic enzymes, two fatty
acid binding proteins (FABP4 and FABP5) were among the top
10 most abundant proteins in the adipocyte, comparable in
expression level to the core nucleosome proteins H4 and H2B
(Table S4). Hence, this compendium of ranked protein abun-
dance should serve as a useful resource for cell biologists.
Comparative Analysis of Proteome and
Phosphoproteome in 3T3-L1 Adipocytes
Comparison of the proteome and phosphoproteome revealed an
overrepresentation of phosphoproteins associated with the
cytoskeleton, plasma membrane (PM), and nucleus, consistent
with the importance of phosphorylation as a key functional
modulator at these locations (Figure 2B). Enrichment of phos-
phoproteins in the PM might be anticipated since this compart-
ment is a hub for protein signaling. Surprisingly, such enrichment
has not been observed in previous studies, with one study
showing an underrepresentation of plasma membrane proteins
(Olsen et al., 2006). It was proposed that this occurred due to
insufficient phosphoproteome coverage to sample low-abun-
dance membrane proteins. The enrichment of these proteins in
our data set reflects the absence of bias against low-abundance
PM proteins and a substantial depth of coverage likely achieved.
In contrast, there was a relative paucity of phosphoproteins
associated with mitochondria and lysosomes. These data
suggest that protein kinases likely have connectivity with a
broader range of substrates at the PM and nucleus compared
with these other locations. Moreover, since the lysosomal sur-
face is a well-known signaling hub for mTOR and extracellularetabolism 17, 1009–1020, June 4, 2013 ª2013 The Authors 1011
Figure 3. Quantification of Insulin/PI3K/Akt-Sensitive Phosphoproteomes
(A) Distribution of all quantified phosphopeptides in inhibitor screens and insulin-responsive sites (purple). Known Akt-mediated (blue box) and mTOR-mediated
(pink box) phosphosites regulated by insulin. Phosphosites are annotated as PI3K/mTOR- (orange squares) or Akt (red triangles)-dependent if their insulin-
mediated phosphorylation was reversed by >40%.
(B) PI3K- and Akt-regulated components of the insulin-regulated phosphoproteome. A subset of these were considered PI3K regulated if they were inhibited by
LY294002 by more than the indicated thresholds and Akt regulated if they were also inhibited by MK2206.
(C) Sequence logos for phosphorylation sites that were insulin regulated.
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this finding raises the possibility that resident lysosomal proteins
are not the principal substrates for these kinases at this location.
To further assess the phosphoproteome coverage of our data,
we mapped the proteins found to contain phosphorylation sites
onto the ranked proteome abundance (Figure 2A). We observed
good coverage of proteins spanning the entire abundance of
the measured proteome, with a relative enrichment of low-
abundance proteins (p = 8.5 3 108, Wilcoxon rank-sum test).
Of course, phosphorylation is not limited to single sites within a
protein, so even with near-exhaustive coverage of phosphory-
lated proteins, there will likely be many phosphorylation sites
that remain out of reach with the current technology or that are
only present at measurable stoichiometry following unique
cellular stimulus.
Comparison with In Vivo Mouse Phosphoproteome
We next compared our data set with a study performed in nine
mouse tissues (Huttlin et al., 2010). We observed considerable
overlap of the identified phosphoproteomes among our study
and themouse tissue study. Our study identified 66% of the total
mouse tissue phosphoproteins (Figure S2A) and 90% of the
phosphoproteins from brown adipose tissue. Combining the
data from these two studies alone identified 57,644 phosphory-
lation sites on over 7,800 proteins (Figure S2B). Phosphosites
identified from brain, spleen, and heart were de-enriched in our
study, while those from insulin target tissues (liver, pancreas,
and brown adipose tissue) were most enriched. This suggests
that cells from these tissues may share a subset of common
phosphoprotein machinery and emphasizes the cell-type-
specific nature of protein phosphorylation.1012 Cell Metabolism 17, 1009–1020, June 4, 2013 ª2013 The AuthoWe identified several phosphorylation sites known to be
important to the actions of insulin and growth factor signaling
in general, such as the activating T loop phosphorylation site of
Akt (T308) and the hydrophobic motif (HM) of Akt1 (S473) not
identified in the mouse tissue phosphoproteome study. The
detection of these and other phosphorylation sites in our data
highlights the importance of system perturbations using growth
factors or other stimuli to activate signaling networks when
studying the phosphoproteome. Under resting or starved condi-
tions, the stoichiometry of many growth factor-regulated phos-
phorylation sites is known to be low, making their detection
unlikely if not impossible.
The PI3K/Akt/mTOR Network
In the studies using PI3K and Akt inhibitors, we quantified 19,507
unique phosphorylation sites on 4,065 proteins (FDR < 1%;
Figure 3A), and around 15% of the sites quantified in either
screen were regulated by insulin (Figure 3A). Many of the
insulin-regulated sites belong to the PI3K/Akt/mTOR pathway,
and phosphorylation of most of these substrates was inhibited
by MK2206 and LY294002, reflecting that these inhibitors target
sequential proximal steps in the canonical insulin signaling
pathway.
Applying a threshold of 2.5 median absolute deviations to the
log2-transformed data (roughly equating to a 2-fold change in
this data set) revealed 3,152 positively regulated and 1,574
negatively insulin-regulated phosphorylation sites on 1,285 and
830 proteins, respectively (Figure 3A). To compare phosphoryla-
tion affected by the PI3K/mTOR and Akt inhibitors, we filtered
class I phosphorylation sites that were quantified in at least
one biological replicate from each of the screens, and forrs
Figure 4. Dynamic Quantitative Analysis of Akt/mTOR Networks
(A) Immunoblot analysis of adipocytes following different insulin-stimulated time points for proteins known to belong to the Akt (blue) and mTOR (pink) pathways.
(B and C) Temporal profiles generated from SILAC-MS data for known direct Akt (B) and mTOR (C) substrates.
(D) Network model depicting the activation of Akt, mTORC1, and mTORC2 by growth factors. See also Figure S3.
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lation sites had to be regulated in the same direction in both
inhibitor screens. This revealed that over 50% of the insulin-
regulated phosphoproteome was blocked by the PI3K/mTOR
inhibitor (Figure 3B and Table S1), confirming the dominance
of these pathways in insulin action. We iteratively explored
multiple stringencies for PI3K-Akt inhibition and observed that,
regardless of the filtering stringency utilized, the Akt inhibitor
blocked around 67% of the insulin-regulated, PI3K-sensitive
phosphorylation sites, suggesting that the majority of PI3K-
mediated growth factor signaling is coordinated through Akt-
dependent mechanisms.
Site-Specific Motifs Enriched in the Insulin-Regulated
Phosphoproteome
Enrichment of amino acids surrounding the phosphorylated
residues can be useful in revealing the broad classes of kinases
that are active in the context of the sample analyzed (Colaert
et al., 2009). Among the insulin-stimulated phosphorylation sites,
we found a significant (p < 0.01) overrepresentation of proline-
directed and basophilic-containing motifs and, correspondingly,
fewer acidophilic sequences (Figure 3C). Proline-directed
sites are phosphorylated by several kinases, including mTOR,
mitogen-activated protein kinases (MAPKs), and cyclin-
dependent kinases (CDKs), while basophilic sequences are
phosphorylated by the AGC kinases Akt, serum and glucocorti-
coid-induced kinase (SGK), p70S6K, and p90S6K, among
others. Many of these kinases are regulated by growth factors,
so enrichment of these motifs in the insulin-regulated phospho-
proteome is expected. Acidophilic kinases include casein
kinases 1 and 2. The de-enrichment of these sequences in the
insulin-regulated phosphoproteome indicates that acidophilic
kinases are constitutively active in adipocytes.Cell MThe consensusmotifs for insulin-regulated, PI3K/mTOR-regu-
lated, and Akt-regulated phosphorylation sites were found to be
remarkably similar, with only modest differences between these
classes of phosphosites (Figure 3C). For example, Akt-stimu-
lated phosphorylation sites appear to have a greater preference
toward threonine and serine residues in the +1 and +2 positions,
respectively, when compared with PI3K/mTOR-stimulated sites.
This similarity likely reflects the dominance of Akt and associated
AGC kinases as downstream components of the PI3K/mTOR
pathways and the tight connectivity of these signaling networks.
Temporal Clustering of the Insulin-Regulated
Phosphoproteome
We next investigated the dynamics of insulin-regulated phos-
phorylation (Figure 1B). We initially focused on temporal profiles
of phosphorylation sites known to belong to pathways regulated
by Akt and mTORC1 since, according to the data from our
inhibitor screens, the PI3K-Akt/mTOR axis accounts for over
half of the insulin-regulated phosphoproteome. We observed
segregation in the temporal profiles of phosphorylation sites
belonging to these two pathways (Figure 4A), with Akt
substrates phosphorylated rapidly, reaching a maximum within
1 min of insulin stimulation (Figure 4B). In contrast, mTORC1
substrateswere phosphorylated substantially slower (Figure 4C).
This latency may reflect differences in the molecular mecha-
nisms governing activation of the kinases regulating
these pathways (Figure 4D) or spatial differences in kinase and
substrate localization.
To classify the temporal patterns of phosphorylation in an
unbiased manner, we performed unsupervised clustering (fuzzy
c-means) (Futschik and Carlisle, 2005) of the time course data.
Approximately 50% of the temporal phosphorylation patterns
showed a sustained increase with insulin, while the remainderetabolism 17, 1009–1020, June 4, 2013 ª2013 The Authors 1013
Figure 5. Temporal Phosphorylation in Response to Insulin Reveals Signaling Network Topology
Data from the literature were used to construct a cell signaling network. Proteins identified in this study were annotated with their respective insulin-dependent
phosphorylation sites color coded according to the temporal patterns derived from unsupervised clustering (fuzzy c-means), shown at the right. Complete
clusters (A–R) are shown in Figure S3 and listed in Table S2. See also Figures S4 and S5.
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utility of these temporal data for identifying the proximity of
signaling components, we constructed a network comprising
over 100 well-described phosphorylation sites and overlaid the
unsupervised clustering results (Figure 5). Examination of this
network reveals functional temporal clusters reflecting signaling
connectivity between the nodes. For example, upstream ele-
ments such as the tyrosine-phosphorylated insulin receptor
and IRS1, as well as Akt regulatory sites, were found in the
most rapid cluster (cluster A), while MEK1/MEK2-mediated acti-1014 Cell Metabolism 17, 1009–1020, June 4, 2013 ª2013 The Authovation of ERK1 and ERK2 (cluster C) and the ERK substrate
p90RSK (cluster J) were slower (Figure 5).
Interestingly, all well-characterized Akt substrates were found
in the fastest clusters (A and B), together with the activation sites
of Akt (T308 and S473), while p70S6K and its substrate (S6) were
found together in slower clusters (clusters D–F) (Figure 5). This
suggests that kinase activation alone is the rate-limiting step
for substrate phosphorylation and that in vivo substrate phos-
phorylation kinetics could be used as a powerful predictor for
identifying previously unknown, physiological kinase-substraters
Cell Metabolism
Dynamic Adipocyte Phosphoproteomerelationships. This is exemplified by phosphorylation of Bcl2
antagonist of cell death (BAD), since BAD contains both Akt
(S99, cluster B) and p90RSK (S75, cluster D) phosphorylation
sites (Figure 5). Given that Akt is found in the most rapid cluster,
one explanation for this temporal specificity is that Akt-depen-
dent phosphorylation confers conformational changes within
substrates, thereby promoting access to other kinases; alterna-
tively, differential subcellular localization of substratesmight limit
the kinetics of phosphorylation. The rapid phosphorylation of Akt
substrates at distal cellular locations (e.g., forkhead box-O
[FOXO]), however, argues against this. Another possibility is
that this occurs due to carefully tuned, intrinsic-specific activities
of each kinase toward different substrates. The deregulation of
this finely tuned specificity (due, for example, to hyperactive or
upregulated kinase expression, as is often observed in tumors
[Yuan and Cantley, 2008; Zoncu et al., 2011]) may therefore
explain how dysregulated signaling can lead to uncontrolled tu-
mor growth and proliferation. Hence, temporal information is
likely to be a revealing determinant of network connectivity.
Predicting Kinase Substrates from Integrated Global
Phosphoproteomics Data
Amajor challenge in studying protein phosphorylation is defining
physiological kinase-substrate relationships. This is difficult in
light of the loss of sequence specificity that occurs for many
kinases in vitro. For example, the evolutionarily related AGC
kinases Akt and p70S6K phosphorylate substrates with indistin-
guishable motifs in vitro (Manning and Cantley, 2007), yet our
temporal data clearly segregate known Akt and S6K substrates.
Due to the substantial resolution of these closely related kinases,
we sought to utilize our phosphoproteomics data to develop an
integrative method of enhanced kinase-substrate prediction. To
achieve this, we applied a machine learning approach utilizing
support vector machines (SVMs) (Ben-Hur et al., 2008) and
curated positive training sets from the literature (Tables S2 and
S3) to sensitively predict cognate kinase-substrate relationships
using the combined data from both of our large-scale phospho-
proteomics screens (Figure S4A). Regarding selection of positive
training sets, substrates for which there were multiple lines of
evidence from different sources were given preference. We
reasoned that careful selection of true positives for the training
sets was critical due to the reduced specificity that many protein
kinases may have displayed under in vitro assay conditions.
Residual phosphorylation sites from the remaining data set
were treated as negative examples (see Supplemental Experi-
mental Procedures).
Kinase-substrate prediction classifiers were trained for Akt,
mTORC1, and PKA, since these kinases collectively represent
a wide range of the actions of insulin and are implicated in a
diverse range of biological processes of broad significance.
Features used for classification were selected to describe three
diverse characteristics of each substrate: (1) the amino acid
sequence surrounding the phosphorylated residue, (2) the
response of the phosphosite to the PI3K/mTOR and Akt inhibi-
tors (compared with insulin alone), and (3) the temporal profile
of phosphorylation in response to insulin (Figures S3 and S4B).
Using this approach, we generated a normalized prediction
score for Akt, mTORC1, and PKA for each phosphorylation site
that was quantified in the time course data set (Table S2). A deltaCell Mscore was also calculated to determine whether the prediction
score for a specific substrate was substantially higher for
another kinase. We then used a Pareto ranking approach to
objectively incorporate both ensemble prediction scores and
delta scores for prioritizing and ranking potential Akt, mTORC1,
and PKA substrates for follow-up molecular characterization
(Figure S5A and Table S2). The average temporal profiles of
the top 50 ranked predictions for each kinase closely resemble
the established profiles of known substrates (Figure S5B),
and the estimated sensitivity and specificity of the approach
(Figure S5C) indicated that the SVMs are successfully predicting
substrates based on their temporal characteristics.
Insulin Regulates Diverse Cellular Processes through
Convergence on Common Targets
While the high-ranking Akt, mTORC1, and PKA predictions from
ourmachine learning approach includedmany known substrates
for each kinase, there were also many phosphorylation sites not
previously recognized as part of the insulin signaling network.
Many of these previously unrealized phosphorylation sites likely
represent previously unrealized actions of insulin. For instance,
putative mTORC1 sites in Ulk1 and Ulk2, the ubiquitin-specific
processing protease 32 (Usp32), the La ribonucleoprotein
domain family member 4B (Larp4B), the poly(rC)-binding protein
1 (Pcbp1), and topoisomerase II homolog 1 (Patl1) (Figure S5A
and Table S2) suggest possible mechanisms of regulation of
autophagy, ubiquitin-dependent protein turnover, and mes-
senger RNA (mRNA) stability. Moreover, we found phosphoryla-
tion sites on Patl1 and Larp4B that were predicted to be PKA
substrates (Figure S5A). This points tomRNA turnover as amajor
determinant of insulin-regulated cellular growth and demon-
strates that insulin regulates cellular processes by coordinated
control of numerous signaling pathways that converge on com-
mon targets. Consistent with this, Akt phosphorylation of
Enhancer of mRNA-decapping protein 3 (Edc3) and butyrate
response factor 1 (Brf1) regulate mRNA stability in mammalian
cells (Larance et al., 2010; Schmidlin et al., 2004) (Figures 5
and S5A). Other predicted substrates imply nascent areas of
mTOR biology, including vesicle trafficking and endocytosis via
the Rab effector Micall1, the Rab guanine nucleotide exchange
factor Dennd4C, and the Rab binding protein Plekhm1, as well
as uncharacterized sites on a-Raf and c-Raf, which may point
to crosstalk between mTOR and MAPK signaling pathways.
Candidate Akt substrates include butyrate response factor 2
(Brf2), an mRNA-binding protein that promotes mRNA deadeny-
lation and degradation. A homologous site on Brf1 is a known Akt
substrate (Schmidlin et al., 2004), supporting our prediction that
Brf2 is likely an Akt substrate. Other putative Akt substrates are
the insulin receptor substrates 1 and 2 (IRS1/IRS2), Stress-
activated map kinase-interacting protein 1 (SIN1), and etopo-
side-induced 2.4 kb transcript (EI24) (Figure S5A). EI24 is a
p53-induced DNA damage response gene involved in growth
suppression and apoptosis, located on a region in the human
genome most consistently deleted in solid tumors (11q23)
(Gu et al., 2000). We verified the phosphorylation of EI24 in
HEK293 cells and showed that this was blocked by MK2206,
but not by rapamycin (data not shown). The potential regulation
of EI24 by Akt is of considerable interest, as it may represent
a mechanism by which Akt mediates cell survival and apoptosis,etabolism 17, 1009–1020, June 4, 2013 ª2013 The Authors 1015
Figure 6. Akt Is the Physiological Kinase for SIN1 T86, and its Phosphorylation Directly Regulates mTORC2 Activity
(A) SIN1 domain structure and sequence homology of the region surrounding T86. TORC, putative mTORC-binding domain; CC, coiled-coil domain; CRIM,
conserved region in the middle domain; RBD, Raf-like Ras-binding domain; PH, pleckstrin homology domain. Enlarged is the region containing the insulin-
responsive phosphorylation site, T86. Residues surrounding several other known Akt substrates (AS160 T642, FOXO1A S256, TSC2 S939 and BAD S99) are
shown.
(B) Endogenous SIN1 is rapidly phosphorylated in response to insulin and blocked by pretreatment with the Akt inhibitor MK2206. 3T3-L1 adipocytes were serum
starved, treated with MK2206 (MK; 10 mM, 30 min), and stimulated with insulin (100 nM) for the indicated times, and samples were assessed by immunoblotting.
(C) Insulin-stimulated phosphorylation of endogenous SIN1 T86 is blocked by MK2206 and GDC-0068, but not by rapamycin. HEK293 cells were serum starved
overnight, treated with MK2206 (MK; 10 mM and 1 mM), GDC-0068 (GDC;10 mM), or rapamycin (50 nM) followed by insulin (200 nM, 10 min), and samples were
analyzed by immunoblotting.
(D) Akt in vitro kinase assay performed using recombinant GST-Akt results in specific phosphorylation of SIN1 at T86 and is blocked by GDC-0068 (GDC*; 10 mM)
added to the in vitro kinase reaction.
(E) Expression of SIN1, but not SIN1 T86A mutant, in SIN1/ MEFs rescues mTORC2-dependent signaling. SIN1 WT or phosphomutants (T86A, T86E) were
expressed in SIN1/ MEFs, and cells were selected by FACS. Cell lines were serum starved and stimulated with insulin, and samples were analyzed by
immunoblotting.
(legend continued on next page)
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of cellular proliferation and cancer.
Identification of SIN1 as a Direct Akt Substrate that
Regulates mTORC2 Activity
One predicted Akt substrate of particular interest was SIN1,
an indispensible subunit of mTORC2 (Figure 4D) required for
complex assembly and mTORC2 kinase activity (Jacinto et al.,
2006). We identified rapid phosphorylation of SIN1 on T86 in
response to insulin in our MS-based proteomics experiments
(cluster A; Figure 5) along with Akt (T308) and numerous Akt
substrates (area under curve [AUC] = 0.86; Figure S4B). SIN1
T86 is located in a highly conserved region of the protein (Fig-
ure 6A). We verified the phosphorylation of SIN1 T86 by gener-
ating a phosphospecific antibody and confirmed that SIN1 T86
phosphorylation in response to insulin occurred on a timescale
similar to that of Akt S473 and Akt substrates AS160 and
GSK3 in 3T3-L1 adipocytes and HEK293 cells. However, phos-
phorylation of SIN1 was temporally distinct from S6K and the
S6K substrate S6 (Figures 6B and S6A); it was inhibited dose
dependently by the allosteric Akt inhibitor MK2206 and blocked
by the ATP-competitive Akt inhibitor GDC-0068, but not by the
mTORC1 inhibitor rapamycin (Figures 6B and 6C). Moreover,
Akt phosphorylated SIN1 T86 in vitro, and this phosphorylation
was blocked by GDC-0068 (Figure 6D). Together, these findings
confirm that Akt is the physiological kinase of SIN1 T86.
We predicted that Akt-mediated phosphorylation of SIN1
might be involved in regulating the activity of mTORC2 because
its phosphorylation occurred on a timescale that would support
such a function relative to Akt S473 phosphorylation, and PI3K
inhibition impairs the activation of mTORC2 (Frias et al., 2006).
One way in which SIN1 T86 might regulate mTORC2 is by
affecting formation of the complex, since SIN1 is essential for
mTORC2 complex stability (Jacinto et al., 2006). To test this,
we expressed wild-type (WT) or phosphomutant (T86A) SIN1 in
SIN1/ MEFs and selected for cells expressing SIN1 similar to
endogenous levels. We found that SIN1 T86A was equally
capable of forming mTORC2, since immunoprecipitation of
Rictor copurified both the phosphomutant andWT SIN1 equally,
suggesting that formation and stability of the complex was not
impaired (Figure S6B). In contrast, insulin-dependent phosphor-
ylation of Akt S473 was blunted in SIN1 T86A cells, but not in
SIN1 WT cells (Figure 6E), suggesting that phosphorylation of
SIN1 T86 by Akt directly regulates mTORC2 activity. Consistent
with this, substitution of the phosphorylated residue with a
phosphomimetic (T86 to glutamic acid, T86E) restored growth
factor-dependent mTORC2 signaling (Figures 6E and S6C).
In addition to S473, Akt is also phosphorylated at an additional
site (T450) by mTORC2. Consistent with this, Akt T450 phos-
phorylation was abolished in SIN1/ cells (Facchinetti et al.,
2008) (Figure 6E). Intriguingly, while SIN1 WT and SIN1 T86E
completely rescued Akt T450 phosphorylation, this was not the
case for SIN1 T86A; however, this diminution was not as marked(F) In vitro kinase activity of endogenousmTORC2 isolated from cells is enhanced
MK2206 (MK; 10 mM), but not rapamycin (R; 50 nM). LY294002 (LY*; 15 mM) was
(G) mTORC2 isolated from SIN1/ MEFs reconstituted with SIN1 WT or phosp
activity in in vitro kinase assay, with enhanced mTORC2 activity isolated from T8
(H) Model depicting growth factor-dependent activation of mTORC2 mediated b
Cell Mas that observed for Akt S473 phosphorylation. Collectively, this
suggests that mTORC2 has differential substrate sensitivities for
T450 versus S473 of Akt in vivo, and phosphorylation of SIN1 on
T86 potentiates mTORC2 activity toward these sites. Con-
sequently, ablation of SIN1 phosphorylation at T86 has a greater
effect on S473 phosphorylation and, in turn, Akt activation.
We next tested whether Akt directly regulates mTORC2
activity in response to growth factors via the phosphorylation
of SIN1 T86, using an mTORC2 in vitro kinase assay with exog-
enous (inactive) Akt as the substrate. mTORC2 complexes
obtained from cells pretreated with the Akt inhibitor MK2206,
but not rapamycin, had impaired mTORC2 activity and a
concomitant block of SIN1 T86 phosphorylation (Figure 6F). In
this assay, we used the mTOR inhibitor LY294002 as a control
by adding the compound directly to the in vitro kinase reaction
to block mTORC2 activity.
We further explored whether the phosphorylation of SIN1
T86 alone was sufficient to directly affect the growth factor-
enhanced activity of mTORC2 by isolating the complex from
the SIN1/ MEFs rescued with SIN1 WT, T86A, and T86E
mutants and performing in vitro kinase assays.mTORC2 isolated
from cells containing SIN1 T86A displayed an impaired growth
factor increase in kinase activity (Figure 6G). Moreover, overex-
pression of the phosphomimetic mutant SIN1 T86E resulted in
enhanced, and growth factor-independent, mTORC2 kinase
activity (Figure 6G). These data indicate that phosphorylation
of SIN1 T86 results in a substantial and direct activation of
mTORC2 kinase activity.
We propose the following model for the activation of mTORC2
(Figure 6H): (1) growth factors activate PI3K, causing accumula-
tion of PIP3 at the PM; (2) Akt translocates to the PM where its
activity is increased by phosphorylation at T308 by PDK1; (3)
mTORC2, probably via the pleckstrin homology (PH) domain in
SIN1 (Pan andMatsuura, 2012; Schroder et al., 2007), also trans-
locates to the PM, and SIN1 is phosphorylated on T86 by Akt,
resulting in activation of the complex; (4) active mTORC2 phos-
phorylates Akt on S473, enhancing and stabilizing the activity of
the kinase; and (5) activated Akt continues to phosphorylate
other substrates.
DISCUSSION
Here we provide a quantitative atlas of dynamic protein phos-
phorylation and show that these large-scale phosphoproteomics
data can be integrated using in silico approaches to delineate
key topological features of this essential signaling network.
These data serve as a resource for future hypothesis-driven
research into both known and currently poorly defined actions
of insulin and other growth factors that converge upon signaling
nodes like Akt that are central to insulin action.
While dysregulated signaling networks downstream of
RTKs are a key feature of diabetes, cardiovascular disease,
and many types of cancer, there is a paucity of systems-wideby insulin stimulation (200 nM, 10min) and blocked by pretreatment of cells with
added directly to the in vitro kinase assay.
homutants (T86A, T86E) displays differential growth factor-stimulated kinase
6E phosphomimetic mutants.
y Akt phosphorylation of SIN1. See also Figure S6.
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Hence, the data described herein brings us a step closer to a
more complete understanding of disease phenotypes. It is
apparent, for example, that the scale of growth factor-regulated
protein phosphorylation, in terms of both functional and
temporal distribution, is much greater than previously appreci-
ated. This underscores the importance of classifying phosphor-
ylation data using context-specific systems. Therefore, the
current study, which focuses on insulin signaling in the adipo-
cyte, will provide an ideal framework with which to move toward
more complex signaling networks in tissues comprising multiple
different cell types and multiple intercellular communication
networks.
Our data highlight the temporal dimension in protein phos-
phorylation as a key indicator of functional behavior and its
modification by extrinsic cues such as growth factors, including
insulin. Two major nodes regulated by insulin are mTOR and
Akt, each of which controls distinct biological endpoints such
as nutrient sensing, protein synthesis, metabolism, and cell
survival. In our quantitative phosphoproteome, we observed
substantial temporal resolution in the activation of these two
pathways. The activation of Akt involves at least eight molecular
events consisting of changes in protein localization, protein-
protein interaction, and conformation. Despite this, Akt was fully
active within 30 s of insulin stimulation, while the activation
of mTORC1 was markedly delayed. The resolution of Akt and
mTORC1 activity (Figures 4B and 4C) is in contrast to the
temporal clustering of Akt and upstream elements (e.g., IR and
IRS). While it might be predicted that mTORC1 activation occurs
after Akt since mTORC1 is downstream of Akt, the extent of the
observed temporal latency is not intuitively obvious from the
biochemistry of mTORC1 activation (Laplante and Sabatini,
2012). Moreover, recent studies have demonstrated that, in
adipocytes, mTORC1 is activated at the same location in the
cell as Akt (Bridges et al., 2012), making it unlikely that this
temporal distinction arises from spatial segregation.
To illustrate the utility of these data for the identification of
kinase-substrate relationships, we employed amachine learning
approach utilizing SVMs. We demonstrated that one of the
predicted substrates, SIN1, is a physiological target of Akt.
Moreover, we found that the site-specific phosphorylation of
SIN1 T86 is responsible for the direct activation of mTORC2
that occurs in response to growth factors. This is intriguing since
mTORC2 is typically considered to be upstream of Akt, as it
phosphorylates Akt at the hydrophobic motif (Sarbassov et al.,
2005), thereby increasing the activity of the kinase (Alessi
et al., 1996). Therefore, our data provide mechanistic insight
into the acute activation mechanisms of mTORC2 and the archi-
tecture of the Akt-mTORC2 signaling network. Previously it was
known that, in response to growth factors, Akt translocates to
the PM and is activated by PDK1 phosphorylation of Akt at
T308 and mTORC2 phosphorylation of Akt at S473 (Figure 4D).
Our data reveal that Akt is intimately involved in a positive
feedback loop with mTORC2. We demonstrate that by phos-
phorylating mTORC2 on SIN1 T86, Akt enhances the activity of
mTORC2, which in turn results in increased feedback phosphor-
ylation onto Akt (Figure 6H). This model unifies the growth factor-
dependent activation of Akt with that of mTORC2 through an
Akt-dependent positive feedback process, providing a more1018 Cell Metabolism 17, 1009–1020, June 4, 2013 ª2013 The Authocomplete picture of the activation mechanisms of both mTORC2
and Akt.
Here we have highlighted only a subset of the biological pro-
cesses that are encapsulated in our data. A cursory analysis
reveals numerous other important pathways that are likely to
be regulated by insulin, as well as other RTKs that invoke
the PI3K/Akt-mTOR pathways. Hence, we expect that many
additional cellular targets of insulin will emanate from studies
of this kind.EXPERIMENTAL PROCEDURES
Cell Culture and Peptide Preparation
3T3-L1 fibroblasts were triple SILAC labeled (Ong and Mann, 2006), differen-
tiated into adipocytes, and used on days 10–12 of differentiation. All large-
scale MS experiments were performed in three biological replicates. For the
inhibitor screens, adipocytes were serum starved then treated with 10 mM
MK2206, 50 mM LY294002, or vehicle (DMSO) for 30 min followed by
100 nM insulin or vehicle for 20min at 37C (Figure 1A). For time course exper-
iments, adipocytes were serum starved then stimulated with vehicle (PBS) or
100 nM insulin for 15 s, 30 s, 1 min, 2 min, 5 min, 10 min, 20 min, or 60 min,
and pooling of SILAC-labeled cells resulted in four groups of cells (Figure 1B).
Following mixing, proteins were acetone precipitated, resuspended in urea,
reduced, alkylated, and digested with endoproteinase Lys-C followed by
trypsin. Peptides were desalted and fractionated by strong anion exchange
(SAX) (Wisniewski et al., 2009) for total-proteome analysis or by strong cation
exchange (SCX) and TiO2 for phosphopeptide analysis (Larsen et al., 2005;
Olsen et al., 2006). Eluted peptides were dried under vacuum before being
loaded onto in-house packed C18 stop and go extraction (STAGE) tips.
MS
Eluted peptides were resuspended in MS loading buffer (2% MeCN, 0.3%
trifluoroacetic acid [TFA]) and loaded onto a 20 cm column with a 75 mM inner
diameter, packed in house with 3 mM C18 ReproSil particles (Dr. Maisch
GmbH). An EASY-nLC system was connected to the mass spectrometer
with a nanospray ion source, and peptides were separated with a binary buffer
system of 0.5% acetic acid (buffer A) and 80% MeCN plus 0.5% acetic acid
(buffer B), at a flow rate of 250 nL/min. Peptides were analyzed on an Orbitrap
Velos or Q Exactive benchtop Orbitrap mass spectrometer (Thermo Fisher
Scientific). Up to 10 peptides on the Orbitrap Velos or 15 on the Q Exactive
were fragmented in the HCD cell and analyzed with high resolution (7,500 at
400 m/z) in the Orbitrap detector. Dynamic exclusion and lock-mass were
enabled (m/z 445.120025).
MS Data Analysis
Raw mass spectrometry data were processed using the MaxQuant software
(Cox and Mann, 2008) version 1.2.3.3, using the default settings with minor
changes (see Supplemental Experimental Procedures). Database searching
was performed using the Andromeda search engine integrated into the Max-
Quant environment (Cox et al., 2011) against the mouse international protein
index (IPI) database v3.68, concatenated with known contaminants as well
as the reversed sequences of all entries. Protein, peptide, and site FDRs
were controlled at a maximum of 1%.
Statistical Analysis
Data analyses were performed using Microsoft Office Excel, the R software
environment, and the bioinformatics platform Perseus (Max Planck Institute
of Biochemistry, Munich). Gene ontology (GO) annotation enrichment analysis
was performed in Perseus, and significance was assessed using Fisher’s
exact test. The whole quantified phosphoprotein data set was used as a back-
ground data set, and the Benjamini-Hochberg FDR method was used for
multiple hypotheses testing (FDR < 0.02). Motif analysis was performed using
iceLogo (Colaert et al., 2009), using percent difference for scoring, a signifi-
cance threshold of 0.01, and a sequence window of 13 amino acids surround-
ing the phosphorylated residues of class I insulin-regulated phosphorylationrs
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Dynamic Adipocyte Phosphoproteomesites (Table S1). The non-insulin-regulated phosphoproteome was used as a
reference data set.
Kinase Substrate Prediction using Machine Learning
The workflow of the analysis is shown in Figure S4A. An ensemble of SVMs
were trained using positive training sets curated from the literature to recog-
nize Akt, mTORC1, and PKA substrates, using features extracted from the
combined analysis of our large-scale phosphoproteomics studies. The fold
ratios for each phosphorylation site over the 9 time points were scaled
between 0 and 1. The area under the curve (AUC) for each phosphorylation
site was calculated (Figure S4B) and subjected to polynomial curve fitting
(order = 2). These were used as descriptive features for SVM training. Other
features used for SVM training were the average fold ratios for each site across
all time points, the fold ratios with insulin in the presence or absence of
inhibitors, and the position-specific scoring matrix of amino acids surrounding
the phosphorylation site (sequence window of 13 amino acids).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cmet.2013.04.010.
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